Sandra L. Kane-Gill, PharmD, MS, FCCM, FCCP  is a co-investigator on the study “The impact of a clinical pharmacist managed acid suppression program on inappropriate therapy in general ward patients”. This study was selected as a finalist in the Great Eight Platform Presentation for Best Paper Competition. It will be presented at the American College of Clinical Pharmacists Annual Meeting in Austin, Tx in October, 2014.

Kane-Gill is an associate professor in the pharmacy and therapeutics department  at the School of Pharmacy.

fac_111113_KaneGill_0064

Leave a comment